Ameriprise’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.7M Sell
865,145
-347,485
-29% -$13.7M 0.01% 982
2026
Q1
$43.1M Sell
1,212,630
-102,300
-8% -$3.83M 0.01% 947
2025
Q4
$50.2M Buy
1,314,930
+144,229
+12% +$5.52M 0.01% 876
2025
Q3
$44.1M Buy
1,170,701
+1,164,191
+17,883% +$42.6M 0.01% 956
2025
Q2
$230K Sell
6,510
-11,633
-64% -$382K ﹤0.01% 3782
2025
Q1
$586K Sell
18,143
-4,851
-21% -$163K ﹤0.01% 3425
2024
Q4
$765K Buy
+22,994
New +$775K ﹤0.01% 3360

Other funds holding TCAF

Ameriprise's TCAF Position: Q2 2026 in Review

Ameriprise reduced its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 29% in Q2 2026, selling an estimated $13.7M and leaving 865,145 shares worth $46.7M. The position accounts for 0.01% of the portfolio, ranked #982.

Ameriprise first reported a position in TCAF in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.2M in Q4 2025. 357 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • Ameriprise held 865,145 shares of T. Rowe Price Capital Appreciation Equity ETF worth $46.7M as of Q2 2026.
  • Ameriprise sold 347,485 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $13.7M.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.01% of Ameriprise's portfolio in Q2 2026, its #982 holding.
  • Ameriprise first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • Ameriprise's T. Rowe Price Capital Appreciation Equity ETF position peaked at $50.2M in Q4 2025.
  • 357 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.